ZALEPLON
Active substance: zaleplon
CAPSULE · ZALEPLON 5 mg/1
United StatesActive
Marketing holder: Rising Pharma Holdings, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- ZALEPLON · 5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 4 |
|
| EU 2 |
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-f8b9-74ab-8ad1-818bff62e910,01a120c4-c2e7-743f-a9a9-91af86f14df7,01a120c5-c65c-7f45-a234-b5e90c6ff7fb;count=3 · valid from 2026-10-09 · verified 2026-10-09
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208c-7b57-7a7d-9dac-dd8926a2392c,01a1208c-998c-7780-8981-67a20280bcf9,01a1208c-c2a2-7f4a-aabe-4d32df336734,01a1208d-188e-7d3b-86c8-90aa9a5d9b6c,01a1208e-c130-7ddc-82eb-486dd96b8834;count=20 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 57237-239
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 57237-239 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 57237-239 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 57237-239 · Verified 2026-10-09 · open in source